ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
-2.53%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$44.3B
AUM Growth
+$548M
(+1.3%)
Cap. Flow
+$2.39B
Cap. Flow
% of AUM
5.4%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
2,291
New
20
Increased
497
Reduced
1,558
Closed
210
Top Buys
| 1 |
Apple
AAPL
|
+$215M |
| 2 |
Eversource Energy
ES
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Erie Indemnity
ERIE
|
+$182M |
| 5 |
Factset
FDS
|
+$165M |
Top Sells
| 1 |
Cardinal Health
CAH
|
+$48.8M |
| 2 |
Emerson Electric
EMR
|
+$47.1M |
| 3 |
Walmart
WMT
|
+$41.1M |
| 4 |
Williams-Sonoma
WSM
|
+$36.2M |
| 5 |
IBM
IBM
|
+$35.7M |
Sector Composition
| 1 | Technology | 30.94% |
| 2 | Consumer Staples | 10.31% |
| 3 | Consumer Discretionary | 10.1% |
| 4 | Financials | 9.92% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RC
1701
Ready Capital
RC
$675M
| $194K | ﹤0.01% |
38,187
-10,653
| -22% | -$54.2K |
|
1702
Shoals Technologies Group
SHLS
$1.15B
| $194K | ﹤0.01% |
58,452
-15,365
| -21% | -$51K |
|
1703
Immersion
IMMR
$222M
| $192K | ﹤0.01% |
25,381
-937
| -4% | -$7.1K |
|
|
AVDL
1704
Avadel Pharmaceuticals
AVDL
$1.54B
| $191K | ﹤0.01% |
24,354
-6,238
| -20% | -$48.8K |
|
1705
Barings BDC
BBDC
$994M
| $190K | ﹤0.01% |
19,906
+2,097
| +12% | +$20K |
|
1706
Intellia Therapeutics
NTLA
$1.21B
| $189K | ﹤0.01% |
26,638
-6,766
| -20% | -$48.1K |
|
1707
ARS Pharmaceuticals
SPRY
$1.04B
| $189K | ﹤0.01% |
15,037
-3,426
| -19% | -$43.1K |
|
1708
Fastly
FSLY
$1.08B
| $189K | ﹤0.01% |
29,821
-8,377
| -22% | -$53K |
|
1709
Herbalife
HLF
$958M
| $189K | ﹤0.01% |
21,850
-6,578
| -23% | -$56.8K |
|
|
RWT
1710
Redwood Trust
RWT
$801M
| $188K | ﹤0.01% |
31,020
-8,675
| -22% | -$52.7K |
|
1711
Marten Transport
MRTN
$949M
| $188K | ﹤0.01% |
13,671
-3,825
| -22% | -$52.5K |
|
1712
Xerox
XRX
$456M
| $187K | ﹤0.01% |
38,772
-7,017
| -15% | -$33.9K |
|
1713
Myriad Genetics
MYGN
$642M
| $187K | ﹤0.01% |
21,088
-5,894
| -22% | -$52.3K |
|
1714
PureCycle Technologies
PCT
$2.38B
| $185K | ﹤0.01% |
26,687
-8,032
| -23% | -$55.6K |
|
1715
Spyre Therapeutics
SYRE
$977M
| $184K | ﹤0.01% |
11,378
-1,153
| -9% | -$18.6K |
|
1716
Par Pacific Holdings
PARR
$1.69B
| $183K | ﹤0.01% |
12,835
-3,585
| -22% | -$51.1K |
|
1717
First Advantage
FA
$2.74B
| $183K | ﹤0.01% |
12,967
-3,905
| -23% | -$55K |
|
1718
SunCoke Energy
SXC
$656M
| $182K | ﹤0.01% |
19,738
-5,517
| -22% | -$50.8K |
|
1719
Tronox
TROX
$755M
| $181K | ﹤0.01% |
25,717
-7,738
| -23% | -$54.5K |
|
1720
Evolus
EOLS
$475M
| $180K | ﹤0.01% |
14,959
-3,604
| -19% | -$43.4K |
|
1721
Vir Biotechnology
VIR
$713M
| $179K | ﹤0.01% |
27,591
-5,972
| -18% | -$38.7K |
|
1722
Replimune Group
REPL
$468M
| $179K | ﹤0.01% |
18,313
-2,475
| -12% | -$24.1K |
|
|
BDN
1723
Brandywine Realty Trust
BDN
$761M
| $178K | ﹤0.01% |
39,969
-11,170
| -22% | -$49.8K |
|
1724
Zymeworks
ZYME
$1.15B
| $178K | ﹤0.01% |
14,912
-3,711
| -20% | -$44.2K |
|
1725
Rush Street Interactive
RSI
$2.01B
| $176K | ﹤0.01% |
16,457
-4,953
| -23% | -$53.1K |
|